INITIATION OF THE PHASE 2/3 GAIN TRIAL OF COR388, A NOVEL BACTERIAL VIRULENCE FACTOR INHIBITOR FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD) BASED ON PHASE I A/B SAFETY, PK, BIOMARKER AND EFFICACY DATA

Autor: Detke, Mike, Lynch, Casey, Holsinger, Leslie, Kapur, Shirin, Hennings, Dave, Raha, Debasish, Ermini, Florian, Haditsch, Ursula, Ryder, Mark, Goodman, Ira J., Thein, Stephen G., Dominy, Steve
Zdroj: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2019 15(7) Supplement:P1585-P1585
Databáze: ScienceDirect